Tomohide Tamura

Induction chemotherapy followed by gefitinib and concurrent thoracic radiotherapy for unresectable locally advanced adenocarcinoma of the lung: a multicenter feasibility study (JCOG 0402).

Y. Ichinose, K. Takeda, T. Shibata, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Unpredicted clinical pharmacology of UCN-01 caused by specific binding to human alpha1-acid glycoprotein.

E. Sausville, S. Arbuck, S. Akinaga, 1998, Cancer research.

Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxel.

M. Tsuboi, K. Eguchi, N. Saijo, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical pharmacokinetics and pharmacodynamics of paclitaxel: a 3-hour infusion versus a 24-hour infusion.

N. Saijo, Y. Nishiwaki, T. Tamura, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

Correlation between docetaxel clearance and estimated cytochrome P450 activity by urinary metabolite of exogenous cortisol.

N. Saijo, T. Tamura, H. Kunitoh, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Platinum-based chemotherapy with or without thoracic radiation therapy in patients with unresectable thymic carcinoma.

N. Saijo, K. Kubota, S. Kohno, 2000, Japanese journal of clinical oncology.

Prognostic factors and prognostic staging system for small cell lung cancer.

N. Saijo, Y. Nishiwaki, M. Fukuoka, 1997, Japanese journal of clinical oncology.

Phase I study and pharmacokinetics of CPT-11 with 5-day continuous infusion.

H. Ohmatsu, K. Eguchi, Y. Ohe, 1992, Journal of the National Cancer Institute.

Phase I study of CPT-11 and etoposide in patients with refractory solid tumors.

K. Eguchi, H. Arioka, Y. Sasaki, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I and pharmacological study of paclitaxel given over 3 h with cisplatin for advanced non-small cell lung cancer.

R. Kakinuma, N. Saijo, Y. Nishiwaki, 2001, Japanese journal of clinical oncology.